Paper Details

  1. Home
  2. Paper Details

Etravirine in the treatment of HIV-1: a clinical overview for healthcare professionals.

Author: De SmedtGoedele, KakudaThomas N, MillsAnthony, PeetersMonika, VingerhoetsJohan, WoodfallBrian, YeniPatrick

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

The study found that etravirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a valuable treatment option for a wide range of treatment-experienced HIV-1-infected patients. Etravirine demonstrated durable, superior virologic efficacy over placebo and has a favorable safety and tolerability profile.
Paper Details　
Original Abstract of the Article :
Current HIV treatment guidelines emphasize the importance of using an active antiretroviral therapy regimen that produces full virologic suppression and immunologic competence, while at the same time providing patients with a favorable safety profile and limited risk for development of drug resistan...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2174/157016210793499196

データ提供：米国国立医学図書館（NLM）

Etravirine: A New Oasis in the Desert of HIV Treatment

The desert of HIV treatment is a harsh and unforgiving landscape, where finding the right oasis, or combination of oases, is crucial for survival. The authors of this article discuss the use of etravirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), as a valuable treatment option for patients with HIV-1, particularly those who have developed resistance to other antiretroviral medications. The study highlights the efficacy and safety of etravirine, emphasizing its ability to effectively suppress viral load and its favorable tolerability profile.

The study's findings demonstrate the efficacy of etravirine in reducing viral load, particularly in patients with NNRTI-resistant HIV-1. The authors also point to the drug's favorable safety and tolerability profile, minimizing the risk of adverse side effects. This is like finding an oasis that offers both abundant water and a safe haven from the desert's harsh conditions.

A Beacon of Hope in the Desert of HIV Treatment

This study offers a beacon of hope for patients with HIV-1 who have developed resistance to other medications. Etravirine, like a new oasis in the desert, provides an effective and well-tolerated treatment option, offering a path toward better health and quality of life.

The Importance of Personalized Treatment

This study reinforces the importance of personalized HIV treatment, taking into account individual patient factors and the development of drug resistance. It is like understanding the specific needs of different camel caravans as they journey through the desert.

Dr. Camel's Conclusion

The quest for effective HIV treatments continues, and the discovery of etravirine, a new oasis in the desert, is a significant step forward. This study highlights the importance of finding personalized solutions to the challenges of managing HIV-1, ensuring that patients have access to the best possible care.

Date :
  1. Date Completed 2011-07-18
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

20946097

DOI: Digital Object Identifier

10.2174/157016210793499196

Related Literature

Article Analysis
・Side Effects of etravirine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.